• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PRYTIME MEDICAL DEVICES, INC ER-REBOA; CATHETER, INTRAVASCULAR, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PRYTIME MEDICAL DEVICES, INC ER-REBOA; CATHETER, INTRAVASCULAR, DIAGNOSTIC Back to Search Results
Model Number ER7232A
Device Problems Material Rupture (1546); Device Operates Differently Than Expected (2913)
Patient Problems Death (1802); Low Blood Pressure/ Hypotension (1914); Foreign Body In Patient (2687)
Event Date 12/18/2017
Event Type  malfunction  
Event Description
A 7f prelude sheath introducer kit was used to access the pre-existing left femoral arterial line.A floppy-tipped guide wire was passed through the arterial line, and the line was withdrawn over the guide wire.The 7f sheath with dilator were then passed over the guide wire into the femoral artery, and the dilator and wire were removed.A 7f er-reboa catheter was used to measure the distance from the patient's xiphoid to the left femoral arterial catheter site (40 cm), as well as the distance from the patient's umbilicus to the arterial catheter site (25 cm).It was then introduced through the sheath and advanced to 25 cm.The arterial line setup was connected to the distal port, and a 10cc syringe filled with normal saline was connected to the balloon port.Normal saline was slowly injected into the balloon port until pressure and pulsations were felt, which was after the 10cc.During this time, the bp was observed to slowly improve and stabilized with the systolic blood pressure at approximately 100, at which time the valve was closed.The reboa catheter and introducer sheath were then secured to the patient's thigh with a silk suture and several strips of tape.The bp improved and stabilized, so then patient was taken from ed to ct.While in ct, the pt's bp then slowly decreased.I wore a lead apron and went into the scanner with the patient to interrogate the reboa balloon as the ct c/a/p was continued.I found that the reboa balloon was not holding pressure/volume.I withdrew the syringe and aspirated blood from the balloon port.The md noted that the balloon was not holding volume/staying inflated.The md notes the clinical picture was consistent with a ruptured reboa catheter balloon.The patient's bp persistently decreased, and the ct scan was aborted.The ct scan had shown the reboa catheter was noted with its tip in the aorta, with the balloon desufflated, but noted in the mid-infrarenal aorta.The pt.Was taken to surgery; shortly thereafter, the pt.Went into asystole.Cpr and internal cardiac massage was done, but he passed away.In the following days, the md thought about it and the md is unsure whether the reboa failed or not; she feels it was leaking, but was questioning whether its placement was correct.
 
Event Description
A 7f prelude sheath introducer kit was used to access the pre-existing left femoral arterial line.A floppy-tipped guide wire was passed through the arterial line, and the line was withdrawn over the guide wire.The 7f sheath with dilator were then passed over the guide wire into the femoral artery, and the dilator and wire were removed.A 7f er-reboa catheter was used to measure the distance from the patient's xiphoid to the left femoral arterial catheter site (40 cm), as well as the distance from the patient's umbilicus to the arterial catheter site (25 cm).It was then introduced through the sheath and advanced to 25 cm.The arterial line setup was connected to the distal port, and a 10cc syringe filled with normal saline was connected to the balloon port.Normal saline was slowly injected into the balloon port until pressure and pulsations were felt, which was after the 10cc.During this time, the bp was observed to slowly improve and stabilized with the systolic blood pressure at approximately 100, at which time the valve was closed.The reboa catheter and introducer sheath were then secured to the patient's thigh with a silk suture and several strips of tape.The bp improved and stabilized, so then patient was taken from ed to ct.While in ct, the pt.'s bp then slowly decreased.I wore a lead apron and went into the scanner with the patient to interrogate the reboa balloon as the ct c/a/p was continued.I found that the reboa balloon was not holding pressure/volume.I withdrew the syringe and aspirated blood from the balloon port.The md noted that the balloon was not holding volume/staying inflated.The md notes the clinical picture was consistent with a ruptured reboa catheter balloon.The patient's bp persistently decreased, and the ct scan was aborted.The ct scan had shown the reboa catheter was noted with its tip in the aorta, with the balloon desufflated, but noted in the mid-infrarenal aorta.The pt.Was taken to surgery; shortly thereafter, the pt.Went into asystole.Cpr and internal cardiac massage was done, but he passed away.In the following days, the md thought about it and the md is unsure whether the reboa failed or not; she feels it was leaking, but was questioning whether its placement was correct.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ER-REBOA
Type of Device
CATHETER, INTRAVASCULAR, DIAGNOSTIC
Manufacturer (Section D)
PRYTIME MEDICAL DEVICES, INC
13949 w colfax ave.
ste. 110
lakewood CO 80401
MDR Report Key7193231
MDR Text Key97308113
Report Number7193231
Device Sequence Number1
Product Code DQO
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Type of Report Initial,Followup
Report Date 01/08/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Physician
Device Model NumberER7232A
Device Catalogue NumberER7232A
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/08/2018
Device Age1 DY
Event Location Hospital
Date Report to Manufacturer01/08/2018
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/16/2018
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/18/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
NO OTHER THERAPIES; NO OTHER THERAPIES; PT WAS INTUBATED AND RECEIVING IV FLUIDS.; PT WAS INTUBATED AND RECEIVING IV FLUIDS.; NO OTHER THERAPIES; PT WAS INTUBATED AND RECEIVING IV FLUIDS.
Patient Age70 YR
-
-